{
  "fda_pathway": {
    "regulatory_classification": "Class II Medical Device Software",
    "submission_pathway": "510(k) Premarket Notification",
    "predicate_devices": [
      "CardioRisk Calculator (K123456)",
      "AI-ECG Risk Assessment (K789012)"
    ],
    "de_novo_classification": false,
    "software_classification": "Software as Medical Device (SaMD) - Class IIa"
  },
  "device_description": {
    "intended_use": "AI-powered cardiovascular risk prediction for astronauts and Earth analog populations",
    "indications_for_use": [
      "Cardiovascular risk assessment in healthy adults exposed to microgravity or prolonged immobilization",
      "Longitudinal monitoring of cardiovascular biomarkers",
      "Clinical decision support for space medicine and analog research"
    ],
    "contraindications": [
      "Acute cardiovascular events",
      "Pregnancy",
      "Age < 18 or > 75 years"
    ],
    "warnings_precautions": [
      "Not for use as sole diagnostic tool",
      "Requires clinical interpretation",
      "Biomarker availability dependent"
    ]
  },
  "clinical_evidence_requirements": {
    "clinical_data": {
      "primary_studies": "Prospective validation in target populations",
      "sample_size": "Minimum 200 subjects across populations",
      "endpoints": "Sensitivity, specificity, positive/negative predictive value",
      "comparator": "Standard cardiovascular risk assessment tools"
    },
    "analytical_validation": {
      "accuracy": "Concordance with reference standard \u2265 95%",
      "precision": "Coefficient of variation \u2264 5%",
      "analytical_sensitivity": "Detection of clinically relevant changes",
      "interference_testing": "Common biomarker interferences evaluated"
    },
    "clinical_validation": {
      "clinical_sensitivity": "\u2265 85% for high-risk detection",
      "clinical_specificity": "\u2265 80% for low-risk identification",
      "positive_predictive_value": "\u2265 75% in target population",
      "negative_predictive_value": "\u2265 90% in target population"
    }
  },
  "software_documentation": {
    "software_lifecycle_processes": "IEC 62304 compliance",
    "risk_management": "ISO 14971 risk analysis",
    "quality_management": "ISO 13485 QMS implementation",
    "cybersecurity": "FDA cybersecurity guidance compliance",
    "algorithm_transparency": {
      "model_interpretability": "SHAP values and feature importance",
      "bias_assessment": "Demographic and population bias analysis",
      "performance_monitoring": "Continuous model performance tracking"
    }
  },
  "submission_timeline": {
    "pre_submission_meeting": "Month 1-2",
    "510k_preparation": "Month 3-6",
    "fda_submission": "Month 7",
    "fda_review_period": "Month 8-13 (90-day review + response time)",
    "clearance_target": "Month 14",
    "post_market_surveillance": "Ongoing after clearance"
  },
  "international_regulatory": {
    "european_union": {
      "regulation": "Medical Device Regulation (MDR) 2017/745",
      "classification": "Class IIa",
      "notified_body": "Required for CE marking",
      "clinical_evidence": "EU clinical data requirements"
    },
    "canada": {
      "pathway": "Health Canada Medical Device License",
      "classification": "Class II",
      "requirements": "Canadian clinical data or reliance on FDA"
    }
  }
}